Amgen's most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $227.50 short put and a strike $222.50 long put offers a potential 19.62% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $227.50 by expiration. The full premium credit of $0.82 would be kept by the premium seller. The risk of $4.18 would be incurred if the stock dropped below the $222.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 62.81 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Amgen (AMGN) Dips More Than Broader Markets: What You Should Know
Tue, 08 Mar 2022 23:00:11 +0000
Amgen (AMGN) closed the most recent trading day at $231.10, moving -1.39% from the previous trading session.
AMGEN TO PRESENT LONG-TERM OUTCOMES FOR LUMAKRAS® (SOTORASIB) IN KRAS G12C-MUTATED NSCLC AT AACR 2022
Tue, 08 Mar 2022 21:30:00 +0000
Amgen (NASDAQ: AMGN) today announced that new data from across its oncology portfolio and pipeline will be presented at the American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans, Louisiana.
Global biotech breaks ground on 355-job Holly Springs facility. Here's when hiring will ramp up.
Tue, 08 Mar 2022 02:11:02 +0000
The company has said jobs at the $550 million facility will pay average salaries of more than $119,000 per year.
GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA
Mon, 07 Mar 2022 21:00:00 +0000
Amgen (NASDAQ:AMGN) today announced the groundbreaking of its newest biomanufacturing facility, located in Holly Springs, North Carolina. The facility, expected to be operational by 2025, will support the growing demand for Amgen's medicines that treat serious illnesses such as cancer and heart disease.
3 Top Healthcare Stocks to Buy for March
Sun, 06 Mar 2022 15:45:00 +0000
Here are three healthcare stocks that pair quality with attractive valuations to consider buying in March. The first healthcare stock to purchase this month is the health insurer and pharmacy chain CVS Health (NYSE: CVS). With a $133 billion market capitalization, CVS is the second-largest health insurer in the world behind UnitedHealth Group (NYSE: UNH).
Related Posts
Also on Market Tamer…
Follow Us on Facebook